360 related articles for article (PubMed ID: 33296221)
1. Anticardiolipin Positivity Is Highly Associated With Intrauterine Growth Restriction in Women With Antiphospholipid Syndrome.
Xi F; Cai Y; Lv M; Jiang Y; Zhou F; Chen Y; Jiang L; Luo Q
Clin Appl Thromb Hemost; 2020; 26():1076029620974455. PubMed ID: 33296221
[TBL] [Abstract][Full Text] [Related]
2. Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study.
Saccone G; Berghella V; Maruotti GM; Ghi T; Rizzo G; Simonazzi G; Rizzo N; Facchinetti F; Dall'Asta A; Visentin S; Sarno L; Xodo S; Bernabini D; Monari F; Roman A; Eke AC; Hoxha A; Ruffatti A; Schuit E; Martinelli P;
Am J Obstet Gynecol; 2017 May; 216(5):525.e1-525.e12. PubMed ID: 28153662
[TBL] [Abstract][Full Text] [Related]
3. Triple Antiphospholipid (aPL) Antibodies Positivity Is Associated With Pregnancy Complications in aPL Carriers: A Multicenter Study on 62 Pregnancies.
Lazzaroni MG; Fredi M; Andreoli L; Chighizola CB; Del Ross T; Gerosa M; Kuzenko A; Raimondo MG; Lojacono A; Ramazzotto F; Zatti S; Trespidi L; Meroni PL; Pengo V; Ruffatti A; Tincani A
Front Immunol; 2019; 10():1948. PubMed ID: 31475009
[No Abstract] [Full Text] [Related]
4. Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Hamulyák EN; Scheres LJ; Marijnen MC; Goddijn M; Middeldorp S
Cochrane Database Syst Rev; 2020 May; 5(5):CD012852. PubMed ID: 32358837
[TBL] [Abstract][Full Text] [Related]
5. Risk Factors for Adverse Maternal and Fetal Outcomes in Women With Confirmed aPL Positivity: Results From a Multicenter Study of 283 Pregnancies.
Fredi M; Andreoli L; Aggogeri E; Bettiga E; Lazzaroni MG; Le Guern V; Lojacono A; Morel N; Piette JC; Zatti S; Costedoat-Chalumeau N; Tincani A
Front Immunol; 2018; 9():864. PubMed ID: 29867924
[TBL] [Abstract][Full Text] [Related]
6. Antibody profile of pregnant women with antiphospholipid syndrome and pregnancy outcome after treatment with low dose aspirin and low-weight-molecular heparin.
Glasnović M; Bosnjak I; Vcev A; Soldo I; Kosuta M; Lenz B; Glasnović-Horvatić E; Soldo-Butković S; Mićunović N
Coll Antropol; 2007 Mar; 31(1):173-7. PubMed ID: 17598397
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and management of non-criteria obstetric antiphospholipid syndrome.
Arachchillage DR; Machin SJ; Mackie IJ; Cohen H
Thromb Haemost; 2015 Jan; 113(1):13-9. PubMed ID: 25318976
[TBL] [Abstract][Full Text] [Related]
8. Triple therapy with pravastatin, low molecular weight heparin and low dose aspirin improves placental haemodynamics and pregnancy outcomes in obstetric antiphospholipid syndrome in mice and women through a nitric oxide-dependent mechanism.
Lefkou E; Varoudi K; Pombo J; Jurisic A; Jurisic Z; Contento G; Girardi G
Biochem Pharmacol; 2020 Dec; 182():114217. PubMed ID: 32926874
[TBL] [Abstract][Full Text] [Related]
9. The impact of various entities of antiphospholipid antibodies positivity on adverse pregnancy outcome. An epidemiological perspective.
Spinillo A; Bellingeri C; De Maggio I; Riceputi G; Pandolfi MP; Spada C; Alpini C; Montecucco C; Beneventi F
J Reprod Immunol; 2021 Jun; 145():103304. PubMed ID: 33677238
[TBL] [Abstract][Full Text] [Related]
10. Refractory obstetrical antiphospholipid syndrome: Features, treatment and outcome in a European multicenter retrospective study.
Mekinian A; Alijotas-Reig J; Carrat F; Costedoat-Chalumeau N; Ruffatti A; Lazzaroni MG; Tabacco S; Maina A; Masseau A; Morel N; Esteve-Valverde EE; Ferrer-Oliveras R; Andreoli L; De Carolis S; Josselin-Mahr L; Abisror N; Nicaise-Roland P; Tincani A; Fain O;
Autoimmun Rev; 2017 Jul; 16(7):730-734. PubMed ID: 28478081
[TBL] [Abstract][Full Text] [Related]
11. Management and outcomes of women with antiphospholipid syndrome during pregnancy.
Tao JJ; Adurty S; D'Angelo D; DeSancho MT
J Thromb Thrombolysis; 2023 May; 55(4):751-759. PubMed ID: 36967425
[TBL] [Abstract][Full Text] [Related]
12. Pregnancy success rate and response to heparins and/or aspirin differ in women with antiphospholipid antibodies according to their Global AntiphosPholipid Syndrome Score.
Radin M; Cecchi I; Schreiber K; Rubini E; Roccatello D; Cuadrado MJ; Sciascia S
Semin Arthritis Rheum; 2020 Jun; 50(3):553-556. PubMed ID: 32089355
[TBL] [Abstract][Full Text] [Related]
13. Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity. A European multicentre retrospective study.
Ruffatti A; Salvan E; Del Ross T; Gerosa M; Andreoli L; Maina A; Alijotas-Reig J; De Carolis S; Mekinian A; Bertero MT; Canti V; Brucato A; Bremme K; Ramoni V; Mosca M; Di Poi E; Caramaschi P; Galeazzi M; Tincani A; Trespidi L
Thromb Haemost; 2014 Oct; 112(4):727-35. PubMed ID: 25008944
[TBL] [Abstract][Full Text] [Related]
14. Pregnancy outcome in women with antiphospholipid syndrome on low-dose aspirin and heparin: a retrospective study.
Naru T; Khan RS; Ali R
East Mediterr Health J; 2010 Mar; 16(3):308-12. PubMed ID: 20795446
[TBL] [Abstract][Full Text] [Related]
15. Treatment of 139 pregnancies in antiphospholipid-positive women not fulfilling criteria for antiphospholipid syndrome: a retrospective study.
Del Ross T; Ruffatti A; Visentin MS; Tonello M; Calligaro A; Favaro M; Hoxha A; Punzi L
J Rheumatol; 2013 Apr; 40(4):425-9. PubMed ID: 23418380
[TBL] [Abstract][Full Text] [Related]
16. Hydroxychloroquine in obstetric antiphospholipid syndrome: rationale and results of an observational study of refractory cases.
Khizroeva J; Bitsadze V; Tincani A; Makatsariya A; Arslanbekova M; Babaeva N; Tsibizova V; Shkoda A; Makatsariya N; Tretyakova M; Solopova A; Gadaeva Z; Vorobev A; Khamani I; Aslanova Z; Nakaidze I; Mischenko A; Grigoreva K; Kunesko N; Egorova E; Mashkova T
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6157-6164. PubMed ID: 34044735
[TBL] [Abstract][Full Text] [Related]
17. Non-conventional antiphospholipid antibodies in patients with clinical obstetrical APS: Prevalence and treatment efficacy in pregnancies.
Mekinian A; Bourrienne MC; Carbillon L; Benbara A; Noémie A; Chollet-Martin S; Tigaizin A; Montestruc F; Fain O; Nicaise-Roland P
Semin Arthritis Rheum; 2016 Oct; 46(2):232-237. PubMed ID: 27432776
[TBL] [Abstract][Full Text] [Related]
18. Pravastatin improves pregnancy outcomes in obstetric antiphospholipid syndrome refractory to antithrombotic therapy.
Lefkou E; Mamopoulos A; Dagklis T; Vosnakis C; Rousso D; Girardi G
J Clin Invest; 2016 Aug; 126(8):2933-40. PubMed ID: 27454295
[TBL] [Abstract][Full Text] [Related]
19. EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodies.
Pregnolato F; Gerosa M; Raimondo MG; Comerio C; Bartoli F; Lonati PA; Borghi MO; Acaia B; Ossola MW; Ferrazzi E; Trespidi L; Meroni PL; Chighizola CB
Rheumatology (Oxford); 2021 Mar; 60(3):1114-1124. PubMed ID: 32441742
[TBL] [Abstract][Full Text] [Related]
20. Management of Women with Antiphospholipid Antibodies or Antiphospholipid Syndrome during Pregnancy.
Lee EE; Jun JK; Lee EB
J Korean Med Sci; 2021 Jan; 36(4):e24. PubMed ID: 33496084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
